Emprumapimod
Emprumapimod (PF-07265803) is an orally active and specific inhibitor of mitogen-activated protein kinase p38α MAPK, inhibits LPS-induced production of IL-6, and can be used to study dilated cardiomyopathy induced by the LMNA gene.
Product Specifications
CAS Number
765914-60-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
473.52
Molecular Formula
C24H29F2N5O3
Notes
Research use only, not for human use.
Receptor
P38 MAPK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1084944-01 0.02 mg (E-Coli)
Recombinant Mycobacterium vanbaalenii L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase (mshC)
Ask
View Details MBS1084944-02 0.02 mg (Yeast)
Recombinant Mycobacterium vanbaalenii L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase (mshC)
Ask
View Details